Results 151 to 160 of about 40,578 (245)

Thyroid Storm Precipitated by Diabetic Ketoacidosis and Influenza A: A Case Report and Literature Review

open access: diamond, 2017
Toshiyuki Ikeoka   +8 more
openalex   +2 more sources

Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1036-1048, February 2026.
Abstract Aims To evaluate the effectiveness and safety of early initiation of subcutaneous (SC) basal insulin in combination with intravenous insulin infusion (IVII), compared with IVII alone, for the management of diabetic ketoacidosis (DKA). Materials and Methods A systematic search of PubMed, Embase, Scopus, and the Cochrane Library was conducted to
Kitti Thammakosol   +4 more
wiley   +1 more source

Evaluation of Metabolic and Hydroelectrolytic Disturbances in Patients Diagnosed with Diabetic Ketoacidosis [PDF]

open access: diamond, 2020
Mariana Cornelia Tilinca   +5 more
openalex   +1 more source

A nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1179-1190, February 2026.
Abstract Aims A nationwide observational study was conducted to assess the 12‐month effectiveness of AID systems in the routine care of people with Type 1 diabetes (PwT1D). Methods All PwT1D, adults, and children, who initiated AID between January 1, 2022, and December 31, 2022, were included across 79 centres.
Jean‐Pierre Riveline   +98 more
wiley   +1 more source

Thiazides and hypokalaemia in diabetic ketoacidosis [PDF]

open access: bronze, 1973
K. G. M. M. Alberti, T. D. R. Hockaday
openalex   +1 more source

Efficacy and safety of bi‐weekly cofrogliptin treatment replacing daily dipeptidyl peptidase‐4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open‐label, randomized controlled phase 2 trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1191-1200, February 2026.
Abstract Aim This study aimed to investigate the efficacy and safety of bi‐weekly cofrogliptin treatment as a replacement for daily dipeptidyl peptidase‐4 inhibitors (DPP‐4is) in Chinese patients with type 2 diabetes mellitus (T2DM). Methods This multicenter, open‐label, randomized controlled study assigned participants in a 1:1 ratio to either the ...
Congqing Pan   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy